BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Damlaj M, Snnallah M, Alhejazi A, Ghazi S, Alahmari B, Alaskar A, Al-Zahrani M. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World J Transplantation 2018; 8(7): 252-261 [PMID: 30596032 DOI: 10.5500/wjt.v8.i7.252]
URL: https://www.wjgnet.com/2220-3230/full/v8/i7/252.htm
Number Citing Articles
1
Moussab Damlaj, Mohammad Snnallah, Razan Bashir, Inaam Shehab Eddine, Bader Alahmari, Hind Salama, Ahmed Alaskar, Ayman Alhejazi, Mohsen Alzahrani. Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVADClinical Lymphoma Myeloma and Leukemia 2020; 20(10): 690 doi: 10.1016/j.clml.2020.05.012
2
Ding-Ping Chen, Ying-Hao Wen, Po-Nan Wang, Ai-Ling Hour, Wei-Tzu Lin, Fang-Ping Hsu, Wei-Ting Wang. The adverse events of haematopoietic stem cell transplantation are associated with gene polymorphism within human leukocyte antigen regionScientific Reports 2021; 11(1) doi: 10.1038/s41598-020-79369-w
3
Alexandra Zanin-Zhorov, Bruce R. Blazar. ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host diseaseClinical Immunology 2021; 230: 108823 doi: 10.1016/j.clim.2021.108823